Kringle Pharma, Inc.
Status: Publicly traded
Direct answer
Kringle Pharma, Inc. is publicly traded on JPX under the ticker 4884.T.
Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates...
Can you invest in Kringle Pharma, Inc.?
Yes. Kringle Pharma, Inc. is publicly traded on JPX under the ticker 4884.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kringle Pharma, Inc.
Detailed equity research is provided by MarketSnap.